Objective: Following patent ductus arteriosus (PDA) ligation, preterm infants may develop profound hypotension and respiratory failure. Prophylactic stress hydrocortisone (HC) has emerged as a therapy to prevent complications, postulating these infants do not synthesize steroids because of an immature hypothalamic-pituitary-adrenal axis. The purpose of this study was to compare outcomes in infants who received stress HC before their PDA ligations to those who did not.
Introduction
Patent ductus arteriosus (PDA) is a common condition in preterm infants and is associated with considerable mortality and morbidity. 1, 2 Significant left-to-right shunt through the PDA can cause respiratory distress, cardiac failure, hypotension and decreased end-organ perfusion. 3 Prostaglandin inhibitors, such as indomethacin or ibuprofen, are used to close the PDA, but if pharmacological closure is contraindicated or unsuccessful, surgical ligation is usually performed in most neonatal intensive care units (NICU) according to present clinical practice. 4 Surgery is well tolerated in most infants, but B30% develop severe systemic hypotension and respiratory decline requiring maximum levels of cardiopulmonary support in the postoperative period. 5 It has been suggested that this postoperative cardiorespiratory instability is the reason why the infants that have PDA ligations are at higher risk for bronchopulmonary dysplasia, severe retinopathy of prematurity and neurosensory impairment. 6, 7 Developmental immaturity of the hypothalamic-pituitaryadrenal axis in extremely premature infants may have a role in preventing these infants from mounting an adequate response to stress or illness. 8 It has been well documented that stress hydrocortisone (HC) can be used to treat vasopressor-resistant hypotension. 9, 10 Additionally, studies have shown that premature infants with refractory hypotension have higher blood pressures following a physiological stress dose of HC as well as improved urine output. 11 Use of stress dose HC is becoming increasingly commonplace in NICUs. 12 Whether a prophylactic stress dose of HC before PDA ligation can prevent postoperative hypotension and oxygenation difficulties has not yet been investigated. Despite this, use of stress dose HC preoperatively has crept into practice. The objectives of our study were to compare cardiorespiratory outcomes in patients treated with preoperative stress dose HC to those who did not receive HC before PDA ligation and to obtain information on the association between HC pretreatment of neonates undergoing PDA ligation and potential short-term benefits and risks.
Methods
Medical records of all newborns who underwent PDA ligations at a regional referral center between January 2003 and June 2008 were reviewed. Infants were identified through the cardiovascular surgeons' case load records and a database of all patients admitted to the NICU. The study was approved by the Johns Hopkins University Institutional Review Board.
The ligations were performed by board-certified pediatric cardiothoracic surgeons in the operating room or in the NICU. Use of HC, vasopressors and ventilatory support was at the discretion of the attending physician. The practice of preoperative stress dosing with HC varied by attending.
Data were collected on the preoperative 24 h, as an indicator of baseline stability, and the postoperative 72 h after PDA ligation. Information about HC administration including dosage and duration of therapy was noted. Respiratory support expressed as highest FiO2, highest mean airway pressure and mode of ventilation was collected as was cardiovascular support including inotropic medication dose throughout the preoperative and the postoperative periods. Inotropic medication administration was at the discretion of the physician caring for the patients. However, most physicians at our institution typically provide inotropic support if the mean arterial pressure (MAP) is <30 mm Hg. Post-operative cardiovascular and respiratory support were the main outcome measures. Infant demographics including birth weight (BW), gestational age (GA), age at time of the surgery, prenatal steroid exposure, location of birth, and urine output as a measure of perfusion were collected. Hospital outcomes included survival to discharge and incidence of intestinal perforations, as this has been linked to steroid administration in premature infants.
Results are shown as median (interquartile range) for the continuous variables, and frequency (percentage) for the categorical variables. The groups were compared by nonparametric methods, Mann Whitney U test for continuous variables, as the data were not normally distributed, w 2 or Fisher's exact tests for categorical variables. Analyses were done comparing variables during the preoperative 24 h, and each of the 3 days postoperatively. As there was no difference in results, data representing the cumulative 72 h postoperatively are displayed. Multivariable linear regression analyses were conducted to identify predictors of postoperative cardiorespiratory instability. Although both GA and BW were significantly different between the groups, only GA was added to the regression models because of the collinearity between the variables. A 2-tailed value of P<0.05 was considered significant. Statistical analysis was performed with SPSS 15.0 (IBM, Armonk, NY, USA) for Windows.
Results
Demographic data and baseline characteristics are presented in Table 1 . Seventy infants had PDA ligations during the study period. Thirty infants were treated with stress dose HC preoperatively and 40 infants did not receive prophylactic treatment. Infants who received stress dose HC were significantly more immature and of smaller BW than those who were not treated with preoperative stress dose HC. Age at the time of ligation was similar between groups. Eleven infants were already on steroid therapy for refractory hypotension at the time of their ligation and received stress HC before their ligation. Stress HC doses ranged from 10 to 20 mg m À2 per day, with the majority receiving 20 mg m À2 per day. No infants had gastrointestinal perforations during the study period. A similar number in each group had intestinal perforations associated with necrotizing enterocolitis, six in the HC group and seven in the standard treatment group outside the study period. Rates of survival to discharge were also not significantly different between groups: 97% and 90% in the HC and standard treatment group, respectively. Post-ligation cardiovascular outcomes are illustrated in Table 2 . Post-operatively, the use of dopamine and other vasopressor agents was not different between the groups. Infants in the standard treatment group trended towards more frequently requiring dobutamine and epinephrine pre and postoperatively. In all, 13 of 40 infants in the non-HC group were placed on HC for refractory hypotension postoperatively (persistent hypotension despite dopamine infusion of 20 mcg kg À1 min À1 ). These 13 infants were similar to infants who did not receive HC for refractory hypotension in mean BW, GA and age at surgery (BW 810 g, GA 25 weeks, age at surgery 19 days). Eight of these infants also received postoperative dobutamine and epinephrine. The urine output was significantly less in the standard treatment group in the 24 h preoperatively (4.6 (6.2) vs 3.2 (9.9), P<0.002) as well as the 24 h postoperatively (4.9 (2.0) vs 3.2 (1.8), P ¼ 0.002).
Post-operative respiratory outcomes are shown in Table 3 . Infants in the standard treatment group were more likely to have been on high-frequency ventilation both preoperatively and postoperatively when compared with the HC group. The highest MAP preoperatively was the same in both the groups as was the average MAP postoperatively. The highest preoperative FiO2 and average postoperative FiO2 were similar in both the groups as well. Arterial blood gases were not available on all subjects, therefore, comparison of oxygenation indices was not possible.
In regression models that adjusted for GA, HC treatment was not independently related to respiratory support postoperatively (highest FiO2 or MAP). Respiratory support was not significantly different between groups postoperatively. Respiratory support postoperatively was predicted by preoperative respiratory support. There was no difference between groups in the proportion of infants needing pressor support post ligation. In a regression model that adjusted for GA and included age at the time of ligation, and average dopamine dose in the 24 h before ligation, not receiving stress HC was predictive of higher dopamine dose post ligation, although the difference was small (2.2 mcg kg À1 min À1 ; P ¼ 0.03). Stress HC was not associated with adverse outcomes.
Discussion
We performed this retrospective study to examine whether stress dose HC given to preterm infants before surgical PDA ligation improved postoperative cardiorespiratory stability and found it had no significant effect. GA and BW were lower in the HC group (24 vs 25 weeks, 632 vs 790 g), but age at time of surgery was similar (26 vs 21 days). Contrary to our hypothesis, there was no significant difference between groups in the proportion of infants needing vasopressor support post ligation. Infants who received stress dose HC had lower doses of dopamine postoperatively, but this difference was small and clinically insignificant. Our study also illustrated that although postoperative high-frequency ventilation was more frequent in the standard treatment group, when adjusted for preoperative support, there was no difference. Thus, infants on high-frequency ventilation preoperatively were more likely to be on high-frequency ventilation post ligation, regardless of whether or not they received HC.
Post-operative cardiorespiratory instability in premature infants is a well-known complication of surgical PDA closure. Some infants require prolonged mechanical ventilation, develop chronic lung disease or do not survive to hospital discharge. 2, 5 Frequently these infants require drastically increased levels of cardiac and pulmonary support. Although the pathophysiology for this decompensation is not well understood, recent studies have shown the developmentally immature myocardium of preterm infants may not be able to endure abrupt alterations in left ventricular afterload, which occur post ligation. Left ventricular failure could lead to pulmonary edema and result in difficulty with oxygenation. 4, 13 A study in the preterm baboon showed ligated animals had more severe left ventricular dysfunction, required more cardiovascular support and higher mean airway pressures at 24 h of age compared with animals with persistent PDA that is consistent with what we often see in this population. 14 This acute decompensation experienced by infants post ligation is important because it may place them at higher likelihood for poor long-term outcomes. Kabra et al. 7 found infants whose PDA's were closed surgically were more likely to develop bronchopulmonary dysplasia with the need for supplemental oxygen at 36 weeks post menstrual age, severe retinopathy of prematurity and cognitive delay. Doyle et al. 6 has speculated that the association between surgery and subsequent neurosensory impairment may be related to perioperative cardiorespiratory instability. Our study aimed to investigate methods to prevent this period of acute decompensation.
Why some premature infants are able to tolerate PDA ligation without severe hypotension and respiratory failure, is an unanswered question. Relative adrenal insufficiency may have a role in the way infants vary in their responses to stress. A subset of infants may have an inadequate cortisol response during acute illness that results in changes in vasomotor tone, hypotension and increased dependence on vasopressor support. 13, 15 We postulate that relative adrenal insufficiency may have a role in the postoperative decompensation of some premature infants and, providing HC before the stressful event may aid the infants in producing an appropriate response and possibly prevent poor long-term outcomes. Identifying infants with relative adrenal insufficiency is difficult; measuring cortisol levels may be useful, however, studies have shown that low cortisol levels are not helpful in defining a population who would benefit from HC therapy. 10, 15, 16 In our case, information regarding cortisol levels before treatment was not available. Interestingly, those infants who were not pretreated with prophylactic stress HC but subsequently required HC for pressor-resistant hypotension were not clinically different from others in the non-treated group, indicating the challenge of identifying these infants prospectively.
The concept of using prophylactic HC to prevent cardiopulmonary instability post ligation is rooted in the use of HC for treatment of shock in preterm infants. Seri et al.
12 described the cardiovascular effects of administering physiological doses of HC to preterm infant with refractory hypotension to imitate a stress response. Noori et al. 13 has shown HC improves blood pressure without compromising cardiac function, systemic perfusion or endorgan blood flow in human neonates. The impact of HC on improved blood pressure in our study may be explained by these physiological responses to HC. Thus, the decreased need for vasopressor therapy postoperatively in the HC-treated infant may not be entirely related to relative adrenal insufficiency, but rather the response to the therapy. Interestingly, Yoder et al. 17 used an animal model to demonstrate the relationship between adrenal function and cardiovascular stability, and found an impaired early cortisol stress response was more likely to be associated with cardiac instability.
Although previous studies have shown the potential benefit of stress dose HC in hypotensive neonates, there have been no studies that examine its use before PDA ligation in premature infants. Our study was performed to examine whether prophylactic stress dose HC improved outcomes in this population. However, this was not a randomized trial. Infants who received preoperative stress dose HC were significantly less mature and smaller than those who did not receive HC, despite similar instability. This suggests a significant clinical treatment bias. In our study, GA and BW were significant predictors of post ligation ventilator dependence. This finding is similar to a recent retrospective analysis in which Raval et al. 2 found infants undergoing PDA ligation, having higher BW was associated with survival to discharge without chronic lung disease and having greater GA was associated with survival to discharge. Similarly, the work of Moin et al. 18 showed infants of lower BWs and GAs, who were on relatively higher ventilator support, had an increased use of vasopressors post ligation. Other studies have also shown infants of greater GA and BW are more likely to extubate sooner than more immature, smaller infants post ligation. 2, 3 We postulate prophylactic stress HC may have prevented the smaller infants in our study from worse postoperative cardiorespiratory outcomes, but this is an area that requires further investigation.
Conclusions
In our retrospective review, giving stress HC did not significantly change cardiorespiratory outcomes after PDA ligation. Smaller and younger GA infants were more likely to receive stress dose HC than larger and more mature infants; it is possible that their outcomes were better than if they had not received HC, minimizing the differences between the groups, but this is only speculation. A large prospective study is necessary to determine whether lower BW and shorter GA infants could benefit from HC therapy. Such a study will need to include long-term developmental outcomes and consider preoperative stability. 
